BTW, all these trials -- GS-7977 (sovaldi), IDIX 21437, and now ACH 3422 -- have been run in NZ by the same principal investigator, Professor Ed Gane. This gives me a lot of confidence that the ACH 3422 trial will be run flawlessly and that the results will be credible!!!!